U.S. flag

An official website of the United States government

NM_001376.5(DYNC1H1):c.1628C>T (p.Thr543Met) AND Charcot-Marie-Tooth disease axonal type 2O

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Dec 18, 2023
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000696405.11

Allele description [Variation Report for NM_001376.5(DYNC1H1):c.1628C>T (p.Thr543Met)]

NM_001376.5(DYNC1H1):c.1628C>T (p.Thr543Met)

Gene:
DYNC1H1:dynein cytoplasmic 1 heavy chain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q32.31
Genomic location:
Preferred name:
NM_001376.5(DYNC1H1):c.1628C>T (p.Thr543Met)
HGVS:
  • NC_000014.9:g.101985853C>T
  • NG_008777.1:g.26326C>T
  • NM_001376.5:c.1628C>TMANE SELECT
  • NP_001367.2:p.Thr543Met
  • NC_000014.8:g.102452190C>T
  • NM_001376.4:c.1628C>T
Protein change:
T543M
Links:
dbSNP: rs780247153
NCBI 1000 Genomes Browser:
rs780247153
Molecular consequence:
  • NM_001376.5:c.1628C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Charcot-Marie-Tooth disease axonal type 2O
Synonyms:
CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2O; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2O; Charcot-Marie-Tooth disease, axonal, type 20; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013644; MedGen: C3280220; Orphanet: 284232; OMIM: 614228

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000824966Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely benign
(Dec 18, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002503682Molecular Genetics, Royal Melbourne Hospital

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 30, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000824966.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Molecular Genetics, Royal Melbourne Hospital, SCV002503682.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change is predicted to replace threonine with methionine at codon 543 of the DYNC1H1 protein, p.(Thr543Met). The threonine residue is moderately conserved (100 vertebrates, UCSC), and is located in a coiled coil region that interacts with DYNC1I2 in the Dynein heavy chain N-terminal region 1. There is a moderate physicochemical difference between threonine and methionine. The DYNC1H1 gene is highly constrained for missense variation (gnomAD v2.1.1). The variant is present in a singleton from the South Asian, East Asian, and other subpopulations in a large population cohort ( rs780247153, 3/251,446 alleles, 0 homozygotes in gnomAD v2.1.1). The variant has been identified in a case where a different pathogenic variant in another gene fully explained the phenotype, and in at least three individuals referred for hereditary neuropathy genetic testing who harboured additional variants of uncertain significance in other dominant Charcot-Marie-Tooth disease genes (Invitae personal communication, Royal Melbourne Hospital). Multiple lines of computational evidence have conflicting predictions for the missense substitution (4/6 algorithms predict deleterious). Based on the classification scheme RMH Modified ACMG Guidelines v1.3.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2_Supporting, PP2.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024